Social Supports

Support for Establishment of Funded Laboratory

In April 2015, Sumitomo Dainippon Pharma made a donation to support the establishment of the Department of Drug Discovery Medicine, a funded laboratory established by the Graduate School of Medicine, Kyoto University with the aim of developing human resources to undertake drug discovery in industry and academia.

The Japan Epilepsy Research Foundation

The Japan Epilepsy Research Foundation was originally founded in commemoration of the 90th anniversary of the foundation of Dainippon Pharmaceutical. The Foundation's purpose is to promote research related to the causes and presentation of epilepsy, methods for diagnosing and containing the clinical symptoms and attacks, and the development of drugs with high efficacy to prevent and treat epilepsy.

Subsequently, on October 1, 2010, the Foundation gained a fresh start as a public interest incorporated foundation after being authorized as qualifying for the new public interest corporation system, which is run based on contributions from Sumitomo Dainippon Pharma and donors, works to promote research on treatments in the field of epilepsy and was established to contribute to the health and healthcare of the public.

JERF provides grants and commendations, holds meetings for reporting research results as forums for announcing its grants and commendations, and publishes an annual research newsletter.
In fiscal 2015, we provided 12 research grants, two overseas study grants, and two Japan Epilepsy Research Grants for Inviting Overseas Researchers to Japan. Sumitomo Dainippon Pharma will continue to contribute to improvements in healthcare and welfare through its support for JERF.

Click here for more information (in Japanese only) on the Foundation's activities
The Japan Epilepsy Research Foundation

Promoting the Vaccine Business

Sumitomo Dainippon Pharma has been involved in the new tuberculosis vaccine business utilizing a human parainfluenza type 2 virus vector since fiscal 2013 as one of the new fields of business and is taking steps to contribute to global health, especially in emerging and developing countries.

Please check here for "the new tuberculosis vaccine business".
http://www.ds-pharma.com/ir/news/2013/20131108.html
http://www.ds-pharma.com/ir/news/2014/20140127-2.html
http://www.ds-pharma.com/ir/news/2014/20140522.html

Research Grants

Sumitomo Dainippon Pharma operates programs calling for researchers to submit research grant applications in the fields of medicine, pharmaceuticals and related fields.

Current Call for Applications

Program: Research grant from Sumitomo Dainippon Pharma (in the field of neurology)
(Information in Japanese only)